Paradigm Capital Management Inc. NY Has $25.34 Million Stock Holdings in The Pennant Group, Inc. (NASDAQ:PNTG)

Paradigm Capital Management Inc. NY trimmed its position in The Pennant Group, Inc. (NASDAQ:PNTG) by 9.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,092,500 shares of the company’s stock after selling 110,400 shares during the quarter. The Pennant Group makes up 1.2% of Paradigm Capital Management Inc. NY’s portfolio, making the stock its 26th biggest position. Paradigm Capital Management Inc. NY owned 3.62% of The Pennant Group worth $25,335,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Covestor Ltd grew its position in shares of The Pennant Group by 3,805.6% during the 1st quarter. Covestor Ltd now owns 1,406 shares of the company’s stock worth $28,000 after buying an additional 1,370 shares during the period. Principal Financial Group Inc. bought a new stake in shares of The Pennant Group in the 1st quarter valued at about $197,000. Bailard Inc. acquired a new stake in shares of The Pennant Group in the 2nd quarter valued at approximately $253,000. Acadian Asset Management LLC acquired a new stake in shares of The Pennant Group in the 1st quarter valued at approximately $218,000. Finally, State Board of Administration of Florida Retirement System bought a new position in The Pennant Group during the 1st quarter worth approximately $279,000. 85.88% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

PNTG has been the topic of several analyst reports. Truist Financial increased their target price on shares of The Pennant Group from $28.00 to $34.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Stephens raised their price objective on The Pennant Group from $28.00 to $32.00 and gave the stock an “overweight” rating in a research note on Thursday, August 8th. Finally, Oppenheimer boosted their target price on The Pennant Group from $28.00 to $34.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th.

The Pennant Group Trading Up 0.7 %

Shares of NASDAQ:PNTG opened at $35.94 on Tuesday. The firm has a market cap of $1.08 billion, a price-to-earnings ratio of 66.56, a PEG ratio of 3.58 and a beta of 2.01. The Pennant Group, Inc. has a 12 month low of $10.31 and a 12 month high of $36.33. The company’s fifty day simple moving average is $31.57 and its 200 day simple moving average is $25.24. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.48.

The Pennant Group (NASDAQ:PNTG) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.02. The firm had revenue of $168.75 million for the quarter, compared to the consensus estimate of $156.71 million. The Pennant Group had a return on equity of 13.74% and a net margin of 3.16%. As a group, research analysts forecast that The Pennant Group, Inc. will post 0.75 EPS for the current fiscal year.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.